Method of preventing and treating hepatic disease using A2B adenosine receptor antagonists
Details for Australian Patent Application No. 2007227021 (hide)
International Classifications
Event Publications
9 October 2008 PCT application entered the National Phase
PCT publication WO2007/109547 Priority application(s): WO2007/109547
22 October 2009 Alteration of Name
The name of the applicant has been altered to Gilead Palo Alto, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007227034-Differential pH probe having multiple reference chambers
2007227000-Apparatus and methods for deployment of linked prosthetic segments
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser